Pillstats
Rx only · Liquid · Oral

Riluzole

Brands: Tiglutik · Teglutik · Riluzole

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN07XX02
RxCUI (US)35623
US makers1 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a81624322025 Q12025 Q22025 Q32025 Q42026 Q1
14
Rx · 2026 Q1
8.4K
Units dispensed
4
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
EDW PHARMA, INCunknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 26, 2024
    SHORTAGEDrug shortage: Riluzole Oral Suspension (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.))

    Riluzole Oral Suspension — reported in shortage by EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.). Therapeutic category: Neurology.

  • Oct 20, 2023
    RECALLRecall (Class II): Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each), RX only, Manufactured for …

    Failed Viscosity Specifications: Out-of-specification test results for viscosity — Recalling firm: ITF PHARMA INC — Distributed to one distributor in TN who may have further distributed.